Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut with Ambitious Expansion Plans Meta Plans 6065 Billion AI Investment Signaling Accelerated Tech Spending Kevin Warshs Potential Fed Leadership Could Reshape Market Intervention Framework Security Incident Near White House May Heighten Market Uncertainty Fintech Firm Mercury Hits 52 Billion Valuation After 200 Million Funding Round Mortgage Rate Snapshot May 27 2026 CBS News Report Polestar Q4 2024 Earnings Massive EPS Miss Highlights Mounting Losses Stock Slides ZDGE Q1 2026 Earnings EPS Miss Weighs on Stock MGM Q1 2026 Earnings EPS Misses Estimates but Stock Gains Slightly NewtekOne Inc 850 Fixed Rate Senior Notes due 2029 NEWTG Q1 2026 Earnings EPS Slightly Misses Estimates Revenue Not Disclosed FLG Q1 2026 Earnings EPS beats estimates as Flagstar delivers positive surprise RMTI Q1 2026 Earnings EPS Misses Estimates Stock Declines on Weak Performance Sabine Royalty Trust SBR Edges Lower Key Levels and Market Dynamics Mesabi Trust MSB Declines Amid Broader Commodity Pressures Key Support Levels in Focus Solitario Resources XPL Slips 167 as Consolidation Continues Near Key Support Main Street Capital MAIN Climbs 052 Nearing Key Resistance Zone Our Bond Inc OBAI Holds Steady Near Support Amid Low Volatility Quantum Computing Stocks Rally as US Government Plans 2 Billion in Grants and Equity Stakes YB Q2 2025 Earnings EPS of 092 Drives DoubleDigit Stock Rally Foxx Development Holdings FOXX Plunges Nearly 16 as Selling Pressure Intensifies SLM Q1 2026 Earnings EPS Surges Past Estimates as Credit Performance Drives Profitability SMFG Q1 2026 Earnings Earnings Miss Drags Shares Despite Stable Core Operations WGRX Q1 2026 Earnings Heavy Loss and Steep Selloff as Transparency Remains Limited First Internet Bancorp INBK Q1 2026 Earnings Massive EPS Beat Driven by Strong Net Interest Income ALK Q1 2026 Earnings EPS Falls Short on Higher Costs Shares Rally on Demand Optimism CCM Q2 2016 Earnings Significant EPS Miss as Company Reports WiderThanExpected Loss DRTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Challenges